Trial Profile
NK1 Receptor Antagonism for Treatment of Anxiety and Craving in Anxious Alcohol Dependent Subjects During Early Abstinence
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Aug 2014
Price :
$35
*
At a glance
- Drugs Tradipitant (Primary)
- Indications Alcoholism
- Focus Therapeutic Use
- 28 Aug 2014 New trial record